Estrella Immunopharma, Inc. Quarterly Current Federal Tax Expense (Benefit) in USD from Q1 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Estrella Immunopharma, Inc. quarterly/annual Current Federal Tax Expense (Benefit) history and growth rate from Q1 2021 to Q2 2023.
  • Estrella Immunopharma, Inc. Current Federal Tax Expense (Benefit) for the quarter ending June 30, 2023 was $20.5K.
  • Estrella Immunopharma, Inc. Current Federal Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $113K.
  • Estrella Immunopharma, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $51.2K.
Current Federal Tax Expense (Benefit), Trailing 12 Months (USD)
Current Federal Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $113K $20.5K +$20.5K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $92.3K $41.2K +$41.2K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-18
Q4 2022 $51.2K $51.2K +$51.2K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-18
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $0 Feb 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.